RBD7022
RBD7022
Phase 1 small_molecule completed
Quick answer
RBD7022 for Hyperlipemia is a Phase 1 program (small_molecule) at Suzhou Ribo Life Science Co. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Suzhou Ribo Life Science Co.
- Indication
- Hyperlipemia
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed